ID29405A - Protein antigen tumor sart-3 yang baru dan peptida-peptida antigen tumornya - Google Patents
Protein antigen tumor sart-3 yang baru dan peptida-peptida antigen tumornyaInfo
- Publication number
- ID29405A ID29405A IDW20010447A ID20010447A ID29405A ID 29405 A ID29405 A ID 29405A ID W20010447 A IDW20010447 A ID W20010447A ID 20010447 A ID20010447 A ID 20010447A ID 29405 A ID29405 A ID 29405A
- Authority
- ID
- Indonesia
- Prior art keywords
- tumor
- antigent
- sart
- proteins
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24266098 | 1998-08-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID29405A true ID29405A (id) | 2001-08-30 |
Family
ID=17092354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20010447A ID29405A (id) | 1998-08-28 | 1999-08-27 | Protein antigen tumor sart-3 yang baru dan peptida-peptida antigen tumornya |
Country Status (14)
Country | Link |
---|---|
US (4) | US7541428B2 (zh) |
EP (1) | EP1116791B1 (zh) |
JP (2) | JP4436977B2 (zh) |
KR (1) | KR100660367B1 (zh) |
CN (1) | CN1264980C (zh) |
AT (1) | ATE412747T1 (zh) |
AU (1) | AU762516B2 (zh) |
CA (1) | CA2340888C (zh) |
DE (1) | DE69939833D1 (zh) |
ES (1) | ES2316191T3 (zh) |
HK (1) | HK1041290B (zh) |
ID (1) | ID29405A (zh) |
NZ (1) | NZ510154A (zh) |
WO (1) | WO2000012701A1 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2340888C (en) * | 1998-08-28 | 2008-08-05 | Kyogo Itoh | Novel tumor antigen protein sart-3 and tumor antigen peptide thereof |
JP2002365286A (ja) * | 2000-11-13 | 2002-12-18 | Kyogo Ito | 細胞性免疫検出法およびその医薬への応用 |
EP1473564A4 (en) * | 2001-09-18 | 2008-12-10 | Greenpeptide Co Ltd | METHOD OF DETECTING CELLULAR IMMUNITY AND ITS APPLICATION TO DRUGS |
US20060240026A1 (en) * | 2003-08-05 | 2006-10-26 | Green Peptide Co., Ltd. | Preventing and/or remedy hematopoietic tumor |
US20080254445A1 (en) * | 2003-09-22 | 2008-10-16 | Kyogo Itoh | Prognosis in Cancer Patients Vaccinated with a Cancer Antigen Peptide-Associated Agent |
JP5114403B2 (ja) * | 2006-07-11 | 2013-01-09 | 株式会社グリーンペプタイド | Hla−a3スーパータイプアレル陽性前立腺癌患者に対する癌ワクチン療法に有用なsart3由来ペプチド |
CN101854945B (zh) | 2007-09-18 | 2015-07-01 | 株式会社绿多肽 | Ctl诱导剂组合物 |
ES2620277T3 (es) | 2010-07-07 | 2017-06-28 | Green Peptide Co., Ltd. | Vacuna peptídica contra el cáncer |
CA2901984A1 (en) | 2013-03-08 | 2014-09-12 | Taiho Pharmaceutical Co., Ltd. | Novel peptide having 5 linked ctl epitopes |
PT3061771T (pt) | 2013-10-21 | 2020-05-06 | Taiho Pharmaceutical Co Ltd | Novo péptido unido a quatro epitopos ctl |
US20210236613A1 (en) | 2018-06-29 | 2021-08-05 | Taiho Pharmaceutical Co., Ltd. | Antitumor agent and evaluation method thereof |
AU2020411439A1 (en) | 2019-12-26 | 2022-08-04 | Taiho Pharmaceutical Co., Ltd. | Agent for adjuvant therapy |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995004542A1 (en) | 1993-08-06 | 1995-02-16 | Cytel Corporation | Cloning and characterization of the complete mage-1 gene |
CA2257531A1 (en) | 1996-06-07 | 1997-12-11 | Kyogo Itoh | Tumor antigen proteins, genes thereof, and tumor antigen peptides |
CA2340888C (en) * | 1998-08-28 | 2008-08-05 | Kyogo Itoh | Novel tumor antigen protein sart-3 and tumor antigen peptide thereof |
CA2296792A1 (en) * | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
AU3395900A (en) * | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
WO2006028565A2 (en) | 2004-06-30 | 2006-03-16 | Whitehead Institute For Biomedical Research | Novel methods for high-throughput genome-wide location analysis |
-
1999
- 1999-08-27 CA CA002340888A patent/CA2340888C/en not_active Expired - Lifetime
- 1999-08-27 WO PCT/JP1999/004622 patent/WO2000012701A1/ja active IP Right Grant
- 1999-08-27 EP EP99940508A patent/EP1116791B1/en not_active Expired - Lifetime
- 1999-08-27 AT AT99940508T patent/ATE412747T1/de not_active IP Right Cessation
- 1999-08-27 DE DE69939833T patent/DE69939833D1/de not_active Expired - Lifetime
- 1999-08-27 CN CNB998125962A patent/CN1264980C/zh not_active Expired - Lifetime
- 1999-08-27 ID IDW20010447A patent/ID29405A/id unknown
- 1999-08-27 AU AU54441/99A patent/AU762516B2/en not_active Ceased
- 1999-08-27 KR KR1020017002677A patent/KR100660367B1/ko not_active IP Right Cessation
- 1999-08-27 ES ES99940508T patent/ES2316191T3/es not_active Expired - Lifetime
- 1999-08-27 NZ NZ510154A patent/NZ510154A/xx unknown
- 1999-08-27 JP JP2000567688A patent/JP4436977B2/ja not_active Expired - Lifetime
-
2002
- 2002-04-15 HK HK02102831.7A patent/HK1041290B/zh not_active IP Right Cessation
-
2004
- 2004-02-20 US US10/781,659 patent/US7541428B2/en not_active Expired - Fee Related
-
2009
- 2009-04-29 US US12/432,700 patent/US7968676B2/en not_active Expired - Fee Related
- 2009-09-11 JP JP2009210191A patent/JP4904384B2/ja not_active Expired - Lifetime
-
2011
- 2011-05-17 US US13/109,976 patent/US8097697B2/en not_active Expired - Fee Related
- 2011-12-14 US US13/326,304 patent/US8563684B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2340888A1 (en) | 2000-03-09 |
HK1041290B (zh) | 2007-03-09 |
AU5444199A (en) | 2000-03-21 |
US7968676B2 (en) | 2011-06-28 |
HK1041290A1 (en) | 2002-07-05 |
US8563684B2 (en) | 2013-10-22 |
US7541428B2 (en) | 2009-06-02 |
US20110243974A1 (en) | 2011-10-06 |
US20060140968A1 (en) | 2006-06-29 |
ES2316191T3 (es) | 2009-04-01 |
CN1324404A (zh) | 2001-11-28 |
CN1264980C (zh) | 2006-07-19 |
JP4436977B2 (ja) | 2010-03-24 |
WO2000012701A1 (fr) | 2000-03-09 |
US8097697B2 (en) | 2012-01-17 |
EP1116791A1 (en) | 2001-07-18 |
JP2010029194A (ja) | 2010-02-12 |
US20120123090A1 (en) | 2012-05-17 |
KR20010074895A (ko) | 2001-08-09 |
AU762516B2 (en) | 2003-06-26 |
DE69939833D1 (de) | 2008-12-11 |
EP1116791A4 (en) | 2002-01-09 |
JP4904384B2 (ja) | 2012-03-28 |
ATE412747T1 (de) | 2008-11-15 |
EP1116791B1 (en) | 2008-10-29 |
KR100660367B1 (ko) | 2006-12-21 |
US20090297544A1 (en) | 2009-12-03 |
NZ510154A (en) | 2002-11-26 |
CA2340888C (en) | 2008-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69937294D1 (de) | Von cyclophilin b abstammende tumorantigen-peptide | |
TW581808B (en) | Compounds for immunotherapy of prostate cancer and methods for their use | |
CY1106806T1 (el) | Dna και πολυπεπτιδια ανθρωπινης tslp | |
DE69703449D1 (de) | Neuroaktive peptide | |
ITTO950367A0 (it) | Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti. | |
CY1114164T1 (el) | Μεθοδος ελεγχου της δραστικοτητας ανοσολογικα λειτουργικου μοριου | |
NZ521396A (en) | Fusion proteins comprising two or more Neisseria polypeptides | |
IL96907A0 (en) | Proteins produced by human lymphocytes,a dna sequence coding for said proteins and their pharmaceutical and biological application | |
ID29405A (id) | Protein antigen tumor sart-3 yang baru dan peptida-peptida antigen tumornya | |
NZ516381A (en) | Lung tumor proteins in the therapy and diagnosis of lung cancer | |
NO20004631D0 (no) | Forbindelser og fremgangsmÕter for terapi og diagnose av lungekreft | |
NZ503763A (en) | Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use | |
ATE394484T1 (de) | Smad 6 und dessen anwendungen | |
EP0911397A4 (en) | TUMORANTANT PROTEINS, THEIR GENES, AND TUMORANTANT PEPTIDES | |
DK1082423T3 (da) | Cyclin E2-gener og -proteiner | |
FR2755144B1 (fr) | Fragments d'anticorps a chaine unique anti-p53 et utilisation | |
ATE397081T1 (de) | Erhöhte expression von proteinen mittels gfp | |
CY1105820T1 (el) | Basb027 πρωτεϊνες και γονιδια απο moraxella catarrhalis, αντιγονα, αντισωματα και χρησεις | |
AU2001238064A1 (en) | 18477, a human protein kinase and uses therefor | |
AU8405798A (en) | A swine hepatitis e virus and uses thereof | |
ATE354657T1 (de) | Basb019 proteine und gene aus moraxella catarrhalis, antigene, antikörper, und verwendungen | |
ID27162A (id) | Peptida antigen tumor yang dibatasi hla-a2 yang berasal dari sart-1 | |
WO2003011903A3 (en) | Identification of specific tumor antigens by means of the selection of cdna libraries with sera | |
ATE281524T1 (de) | Moraxella catarrhalis pilq proteine | |
WO2004089973A3 (en) | Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production |